Imprivata
Healthcare-focused identity and access management software provider.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Imprivata, Inc.
- Entity type
- COMPANY
- Headquarters
- United States
- Market role
- B2B SaaS Provider
- Official website
- imprivata.com
What Imprivata does
Imprivata operates a B2B enterprise software model built around identity and access management for regulated and operationally complex environments. It creates value by embedding authentication, access control, privileged session governance, device security and compliance analytics into customers’ daily workflows, particularly where shared devices, clinical systems and third-party access create elevated risk. The platform approach increases customer stickiness by combining multiple identity, access and monitoring functions under one vendor relationship, with managed services extending deployment and operational support.
Category differentiation
Imprivata is an enterprise identity and access management software vendor, not a consumer identity app or a general-purpose cybersecurity consultancy. It is distinct from pure identity governance vendors because its core strength is operational access workflows, especially in healthcare and shared-device environments.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Imprivata, Inc. is a private B2B software company that provides identity and access management products for healthcare and other mission-critical environments. Its core platform covers passwordless single sign-on, multifactor authentication, privileged access management, mobile and shared-device access, medical device access and compliance analytics. The company is especially focused on frontline and shared-workflow settings where fast authentication, auditability and secure access are operationally critical. Imprivata generates revenue from enterprise software subscriptions and licence-based contracts, modular product add-ons, and managed services. Its direct customers are enterprise IT, security, compliance and clinical technology teams, particularly in healthcare and other regulated sectors. The company has expanded its platform through acquisitions in biometrics, mobility, risk analytics, PAM, third-party access and DACH-region IAM.
Company news briefing
Briefing updated:
Imprivata continues to solidify its standing in healthcare IT security following its recognition in the Constellation ShortList. Recent proprietary research indicating that 72% of healthcare organisations have deployed unapproved AI tools has driven executive focus towards governing agentic AI actions and mitigating physical-world remote access vulnerabilities.
Business model & monetisation
Imprivata monetises through enterprise SaaS and software licensing, typically priced by user, device, module or deployment scope. Revenue is driven by core access management subscriptions, add-on modules such as compliance analytics, PAM, medical device access and patient identity, plus maintenance, support and managed services. The company also benefits from platform expansion within existing accounts through cross-sell of adjacent identity, mobility and compliance capabilities.
- Core enterprise access management software
- Software Subscription
- Add-on modules for PAM, compliance, mobile and device access
- Software Subscription
- Managed services and operational support
- Service Fee
- Maintenance and support on licence-based deployments
- Service Fee
Products & capabilities
No products with linked sources are available in this view.
Products & market categories
Featured market maps
- Bending Spoons & the New Software Empires
This landscape maps the different playbooks behind acquisition-led software growth.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
New Imprivata Research Finds 72% of Healthcare Organizations Have AI Tools or Agents Deployed Without Formal IT Approval
Recorded impact score: 3.5/5
Imprivata's newsroom now features a new press release: 'New Imprivata Research Finds 72% of Healthcare Organizations Have AI Tools or Agents Deployed Without Formal IT Approval' and 'Imprivata Recognized in Constellation ShortListTM for Healthcare IT Security'.
Agentic AI in healthcare means governing action, not just access
Recorded impact score: 3/5
New blog post by Dr. Sean Kelly, Chief Medical and Growth Officer and Sr. VP, Customer Strategy, Healthcare, Imprivata, discussing the need to govern AI agent actions in healthcare beyond just access control.
AI as a clinical actor: Securing the next phase of health automation
Recorded impact score: 3.5/5
Aug 20, 2026 AI as a clinical actor: Securing the next phase of health automation By Fran Rosch, CEO, Imprivata
Imprivata Recognized in Constellation ShortListTM for Healthcare IT Security
Recorded impact score: 5/5
Press Release: Imprivata Recognized in Constellation ShortListTM for Healthcare IT Security
Explore company relationships
Questions about Imprivata
What is Imprivata?
Imprivata is a private enterprise software company that provides identity and access management products, including passwordless access, MFA, PAM, device access security and compliance analytics.
Who uses Imprivata?
Hospitals, healthcare providers and other regulated organisations use Imprivata, primarily through IT, security, compliance, biomedical engineering and clinical operations teams.
How does Imprivata make money?
Imprivata makes money through enterprise software subscriptions and licences, module add-ons, maintenance and support, and managed services.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
28 publicly documented primary sources and citations linked across the market graph.
Continue your research on Imprivata
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.